Genalyte Announces Oversubscribed $50 Million Financing Round to Expand Testing Menu and Deploy Platform
Diagnostic and Analytics Company Aims to Revolutionize Laboratory Testing and Analytics
News provided by
Share this article
SAN DIEGO, Jan. 11, 2021 /PRNewswire/
Genalyte, a leading diagnostics and analytics company, announced today the closure of $50 million in financing. Genalyte s Maverick™ Diagnostic System (MDS) uses silicon chip based photonic ring resonance technology to perform multiple, simultaneous, rapid tests on a small volume of whole blood or serum in twenty minutes. We are energized by the very enthusiastic response from Investors for this latest round of funding, said CEO Ashraf Hanna. Genalyte is uniquely positioned to improve the laboratory diagnostic and analytic space. We ve demonstrated the strength of our technology in our EUA authorized SARS-CoV-2 Multi-Antigen Serology Panel, which is able to measure 26 different antibodies from one dro